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Abstract The yeast AFG3 gene encodes an ATP-dependent 
metaHoprotease belonging to a subgroup of the AAA-family. 
This protease has been suggested to be essential for a metal- and 
ATP-dependent breakdown of incompletely mitochondrially 
synthesized polypeptides in the inner membrane, a process 
proposed to be important for mitochondrial function (Pajic et 
a|. (1994) FEBS Lett. 353, 201-206). Here, we confirm the 
proteolytic activity by site-directed mutagenesis and demonstrate 
that the proteins Coxl, Cox3, Cob, Su6, Sn8 and Su9 are 
substrates of Afg3p. Surprisingly, this proteolytic activity is not 
required for respiratory function and thus presumably also not 
essential for mitochondrial biogenesis. 
Key words: AFG3; RCA1 ; YME1 ; Mitochondria; AAA- 
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1. Introduction 
In yeast mitochondria, seven proteins belonging to com- 
plexes of the respiratory chain and to the F1F0-ATP synthase 
are encoded by the organelle genome, the other subunits of 
these heteromultimeric complexes being nuclear gene products 
[1]. This division of labour implies that mechanisms must exist 
for balancing cytoplasmic and mitochondrial synthesis. Sev- 
eral levels of control such transcription of the nuclear genes, 
translation of mitochondrial mRNAs or fine tuning at level of 
protein degradation are possible [1]. Little is known about the 
last aspect, although earlier work showed that mitochondria 
contain proteases which are capable of ATP-dependent degra- 
dation of excess amounts of unassembled mitochondrial trans- 
lation products (see [2] for a review). In recent years, different 
components of the mitochondrial protein degradation system 
have been identified. In the matrix subcompartment, PIM1 
has two functions: selective protein turnover and degradation 
of misfolded proteins [3]. The ATP-dependent protein degra- 
dation system associated with the inner membrane [4,5] ap- 
pears to be composed of the three putative mitochondrial 
ATP-dependent metalloproteases: Afg3p (Ytal0p), Rcalp 
(Ytal2p) and Ymelp (Ytallp) recently identified [6 11]. 
These proteins belong to a subgroup of a novel ATPase fa- 
mily, the AAA family (see [12] for a recent review). These 
AAA proteins have been proposed to function in specific de- 
gradation of unassembled subunits as demonstrated for 
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Ymelp (its substrate is the unassembled subunit 2 of the cy- 
tochrome c oxidase) [11,13] and/or degradation of incomple- 
tely mitochondrial synthesized polypeptides in the inner mem- 
brane as suggested for Afg3p [14]. However, lack of Afg3p or 
Rcalp also affects the level of functional respiratory chain 
complexes and the assembly of the F1F0-ATP synthase 
[7,9,15]. Ymelp also affects the respiratory chain, but mainly 
at 37°C [11]. Taken together, these ATP-dependent metallo- 
proteases eem to be required for functions important for 
biogenesis of the organelle. 
We isolated the AFG3 gene by genetic omplementation of 
a temperature-sensitive respiratory-deficient mutant [6] and 
have started a functional analysis of the protein to obtain 
more insight into its role in mitochondrial biogenesis. Here, 
we demonstrate hat the proteins Coxl, Cox3, Cob, Su6, Su8 
and Su9 are substrates for the proteolytic activity displayed by 
Afg3p. Surprisingly, a yeast mutant lacking Afg3p's proteoly- 
tic activity is still capable of non-fermentative growth. This 
activity is thus presumably also not essential for mitochon- 
drial biogenesis. 
2. Materials and methods 
2.1. Strains and growth media 
The DW167-1C yeast strain (MATa, 9 + Aintrons, his3-11,15, leu2- 
3,112, ura3-1) is a spore derived from a cross between the strains 
D273K(167)(MATc~, p + Aintrons, met6, lys2) (the mitochondrial 
DNA of this strain, which lacks introns, comes from strain 
KAR(167)(MATa, p+ Aintrons, trp5, karl-l) [16] and was introduced 
by cytoduction) and W303/1Ap ° (MATa, p°, ade2-1, his3-11,15, leu2- 
3,112, ura3-1, trpl-1, canl-lO0). The strain DAY6 (MATa, p+ 
Aintrons, his3-11,15, leu2-3,112, ura3-1, afg3:.'URA3) was obtained 
by transforming DW167-1C with a 2.3 kb HindlII/EcoRl fragment 
from pNG85.1 and selected on minimal medium minus uracil. The 
disruption of AFG3 in the mutant strain DAY6 was confirmed by 
Southern blot analysis (using DNA probes carrying either the AFG3 
gene or the URA3 gene) and tetrad dissection after crossing with 
strain D273UK (MATs, p+, met6, ura3-1, lys2). The strains RAYI 
(MATa, p + Aintrons, his3-11,15, leu2-3,112, ura3-1, AFG3-c-myc) and 
PMY2 (MATa, p+ Aintrons, his3-11,15, leu2-3,112, ura3-1, afg3-2-c- 
myc)(afg3-2 allele carries the mutation E558Q) were obtained by 
transforming DAY6 with a 3.5kb PstI fragment from pCB1 and a 
3.5 kb HindlII/EcoRl fragment from pPN2, respectively, and selected 
on YPGly. Correctness of gene substitution was confirmed through 
Southern blot analysis (using DNA probes carrying either the AFG3 
gene or the URA3 gene). Minimal medium contained 0.67% yeast 
nitrogen base without amino acids, 2% glucose, supplemented with 
histidine, leucine (each at 30 ~tg/ml). YPGal or YPGIy contains 1% 
yeast extract, 1% bacto-peptone and 2% galactose or 2% glycerol, 
respectively. Lactate medium contains 1.5% lactic acid, 2% sodium 
lactate, 8 mM MgSO4.7H20, 45 mM (NH4)~HPO4, 0.5% yeast ex- 
tract, pH 4.5. 
2.2. Preparation of mitochondria nd proteolysis of 
mitochondrially-encoded proteins 
Cells of wild-type and mutant strains were grown aerobically on 
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Table 1 
Generation time of the strains DW167-1C, DAY6, 
PMY2 in medium containing either galactose or lactate 
RAY1 and 
Strain Generation time 
Galactose Lactate 
DW167-1C 2 h 2 h 25 min 
DAY6 3 h 20 h 
RAY1 2 h 2 h 25 min 
PMY2 2 h 2 h 25 min 
The generation time of each strain was determined by measuring the 
turbidity at 600 nm in the exponential phase of cells growing at 30°C 
on a complete medium containing alactose or lactate as carbon 
source. 
YPGal, harvested in the exponential growth phase and mitochondria 
were isolated from protoplasts as described in [17], except hat zymo- 
lyase was used instead of cytohelicase. The synthesis of labelled mi- 
tochondrial translation products and proteolysis reaction were carried 
out according to [14] except hat, after the in vitro translation reac- 
tion, mitochondria were washed three times with 0.6 M mannitol, 
2 mM EGTA, 10 mM Tris/maleate, pH 6.8. 
2.3. Analytical procedures 
SDS-polyacrylamide gelelectrophoresis was done according to [18]. 
Protein concentration was measured by the method escribed in [19]. 
A 
Bovine serum albumin was used as standard. Protein gels were dried 
and exposed to Hyperfilm-Bmax (Amersham). The autoradiograms 
were scanned using the programs Maclmage (Xerox Imaging Systems 
Inc.) and Scan Analysis (Biosoft). 
2.4. DNA manipulations 
Plasmid pP4 (a pUC18 vector containing the 2.9 kb PstI fragment 
carrying the AFG3 gene [6]) was cut with BgllI and BamHl. The 1170 
bp BgllI fragment of plasmid pFL38 containing the URA3 gene was 
inserted into the 3.6 kb BgllI/BamHI fragment from plasmid pP4. The 
resulting plasmid pAURO was cut with NheI and Bglll and blunted. 
After ligation, the 4.9 kb Nhel°/BgllI ° fragment yielded the plasmid 
pNG8. A M13mp8 phage carrying the 0.5 kb BamHI fragment lo- 
cated in the Y-part of the AFG3 gene [6] was cut with HindlII and 
EcoRI. This fragment was blunted and subcloned into pNG8 cut with 
Sinai, giving the plasmid pNG85.1. To construct he AFG3-c-myc 
fusion gene, plasmid pHH6.8 (a pUC18 plasmid containing the 6.8 
kb HindlII fragment from pHB9 [6] was cut with Bsu36I and blunted 
before XbaI cut. The resulting 2.8 kb Xbal/Bsu36I ° fragment was 
subcloned into YCpmycl81 [20] (XmaI°/XbaI) yielding the plasmid 
pCAM. For mutagenesis of the metalloprotease HEXXH active site 
motif, a 2.6 kb HindlII/EcoRI fragment from p44 (this plasmid con- 
tains a shorter form of the 2.9 kb PstI fragment generated after a 
treatment with ExolII and S1 [21]) was subcloned into the multiclon- 
ing site of pSELECT (Promega Corp.). The mutation E558Q was 
introduced with the following synthetic oligonucleotide: 5'- 
GCATGTCCTGCCTGATGATAGGCCACTG-3'. The complemen- 
tary sequence corresponding to the glutamine codon is underlined. 
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Fig. 1. Degradation of mitochondrial translation products ynthesized in presence or in absence of puromycin. The in vitro labelling of mito- 
chondrial translation products was carried out with (+) or without puromycin (-).  Proteolysis of mitochondrially translated products in each 
strain, (A) DW167-1C, (B) DAY6, (C) RAY1 and (D) PMY2, was monitored. After TCA-precipitation, the radioactivity of supernatant (S) 
and pellet (P) fractions was measured at different time points of the proteolytic reaction. 
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The mutation introduced and the surrounding sequences were checked 
by sequencing with appropriate synthetic oligonucleotides a primers. 
The BsgI/NcoI fragment carrying the mutation E558Q was exchanged 
with the corresponding fragment in pCAM giving the plasmid pCAM- 
EQ. Verification of fragment substitution was carried out by sequen- 
cing. To construct he plasmid pCB1, the 0.8 kb BamHl fragment 
from pHB14 [6] (this DNA fragment carries the 3' downstream se- 
quence of AFG3) was blunted and subcloned into pCAM-EQ cut with 
NarI and blunted. To construct the plasmid pPN2, the 2.9 kb HindlII/ 
NarI fragment from pCAM-EQ was blunted and subcloned into pP4 
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Fig. 2. Analysis of the mitochondrial translation products after 0 and 30 min of the proteolytic reaction. Isolated mitochondria were used to 
synthesize proteins in the absence of puromycin. The TCA-pellets at time points 0 and 30 min were resuspended in 50 gl of 5% SDS. An iden- 
tical volume of these both fractions was analysed by SDS-PAGE. The autoradiograms were analysed as described in section 2. (A and D) and 
(B and E) are autoradiograms obtained at two different imes of exposure of samples from strain RAY1 and PMY2, respectively. (C) is an 
autoradiogram obtained in strain DW167-1C. For each proteolytic reaction, the radioactivity present in the supernatant and in the pellet at 
each time point, was measured and summed. The value for each time point was within a range of 3-5% around the average of the values ob- 
tained from the five time points. VarI =protein associated with mitoribosomes; COXI, -II and -III = subunits I, II and III of the cytochrome c 
oxidase; COB = apocytochrome b; SU6, -8 and -9, subunits 6, 8 and 9 of the ATP synthase. Dashed lines indicate the same level of pixels of 
the scan at time: 0 and 30 min for each strain. The peak on the left side of VarI may correspond to the oligomer of SU9. 
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cut with HindIII and NcoI and blunted before the subcloning. South- 
ern blotting and hybridization were as described in [22]. 
3. Results 
3.1. Disruption of  the AFG3 gene and phenotype of  the 
resultant mutant 
To construct an AFG3 null strain, we replaced 73% of the 
coding region with a 1.2 kb BglII fragment containing the 
URA3 gene. This large deletion was necessary to prevent re- 
combination between plasmids carrying a mutated afg3 gene 
and the previously disrupted chromosomal AFG3 locus (sub- 
stitution of the 0.3kb BglII fragment [6] by the URA3 mar- 
ker). 
The AFG3 ° strain (DAY6) has a generation time of 20 h on 
a medium containing lactate as a carbon source, compared 
with 2 h 25 min for the wild-type parental strain (Table 1). 
3.2. Site-directed mutagenesis of the metalloprotease HEAGH 
active site motif of Afg3p 
A protease-deficient version of Afg3p was constructed by 
replacement of Glu-558 by Gln. This residue forms part of the 
sequence motif HEAGH. Studies with the E. coli protease III 
(non-ATP-dependent metalloprotease) which contains a me- 
talloprotease HEXXH motif, have shown that a similar muta- 
tion eliminates protease activity, without effect on zinc-bind- 
ing [23]. The mutated gene was substituted for the disrupted 
allele of strain DAY6 giving strain PMY2 (see section 2). 
Since the protease mutant protein is tagged with a c-myc 
epitope [20], a transformant containing a wild-type AFG3-c- 
myc fusion gene, was used as control (strain RAY1). On 
media containing either lactate or galactose as carbon source, 
the generation time of the strain RAY1 is identical to the 
wild-type strain DW167-1C (Table 1), showing a neutral effect 
of the c-myc-tag present at the C-terminus of Afg3p. Surpris- 
ingly, the generation time of the strain PMY2 is also identical 
to the wild-type strain DW167-1C (Table 1), suggesting that 
protease activity of Afg3p is not essential for respiratory func- 
tion. 
To verify that the E ~ Q mutation indeed eliminates the 
proteolytic activity previously attributed to Afg3p, we assayed 
for degradation of newly-synthesised, incomplete mitochon- 
drial translation products as described in [14]. Proteolytic ac- 
tivity in strain PMY2 is strongly reduced compared to both 
wild-type strains (Fig. 1; panel D vs. A and C, compare S + 
and P+ in each case). 
3.3. Analysis of mitochondrial translation products in the 
protease-deficient mutant PMY2 
We investigated a role of Afg3p in the protein turnover of 
mitochondrial translated products. Therefore, the mitochon- 
drial in vitro translation was carried out in absence of puro- 
mycin. Under these conditions, only mitochondrially-encoded 
proteins are synthesized. As shown in Fig. 1 (compare for 
each strain, S + with S-  and P+ with P-), proteolytic activities 
with or without puromycin of each strain are comparable. 
Electrophoretic analysis of mitochondrial translation products 
formed during incubation of isolated mitochondria, after in 
vitro translation in absence of puromycin, was carried out at 
increasing times of incubation. The results obtained at times 0 
and 30 min, in the strains DW167-1C, RAY1 and PMY2, are 
shown in Fig. 2. 
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In the wild-type strain RAY1, the proteins Su6 and Su8 are 
markedly degraded (Fig. 1; panel A t = 0 vs. t = 30) and their 
degradation is strongly reduced in the protease mutant PMY2 
(Fig. 1 ; panel B t = 0 vs. t = 30). Analysis of shorter exposed 
autoradiograms shows that the proteins Coxl, Cob, Cox3 and 
Su9 are also significantly degraded in the strain DWI67-1C 
(Fig. 1; panel C t = 0 vs. t = 30). We have noted that in the 
strain RAY1, Coxl and Cob display less degradation (Fig. 1; 
panel D t = 0 vs. t = 30). All these proteins are not significantly 
degraded in the protease mutant PMY2 (Fig. 1 ; panel E t = 0 
vs. t = 30). In the strain DAY6, only Cox2 is degraded con- 
sistent with the observation that this protein is a substrate of 
Ymelp [11,13]. Similar degradation of Cox2 is also observed 
in the three other strains. 
4. Discussion 
The results presented in this study provide additional infor- 
mation about the role of Afg3p in mitochondrial biogenesis. 
On one hand, Afg3p is capable of proteolytic breakdown of 
incompletely synthesized mitochondrial translation products 
([14], Fig. 1 ; compare S + and P+ of panels A and C to D). 
In vivo, it could function in the elimination of imcomplete or 
damaged proteins. At the same time, it is also capable of the 
degradation of a specific subset of mitochondrially translated 
proteins: Coxl, Cox3, Cob, Su6, Su8 and Su9. This finding 
suggests that, in vivo, Afg3p may be required, as recently 
proposed for Ymelp [11,13], for protein turnover of mito- 
chondrial proteins which are not or only incompletely as- 
sembled into inner membrane complexes. 
The proteins Coxl and Cob of which the degradation is less 
in the strain RAY1 than in the strain DW167-1C (Fig. 1; 
panel D vs. C), could suggest hat the presence of the c-myc 
tag at the C-terminus of Afg3p interferes omewhat with rec- 
ognition of these two substrates, without affecting intrinsic 
proteolytic activity since the other substrates are degraded 
as in the wild-type mitochondria. Interestingly, two missense 
mutations in the C-terminus of E. coli FtsH, an Afg3p and 
Rcalp homologue, affect its substrate recognition [24,25]. 
Results presented in Table 1 clearly show that the proteo- 
lytic activity of Afg3p is not essential for mitochondrial func- 
tion since the protease-deficient mutant confers a wild-type 
respiratory growth to yeast cells (Table 1). This behaviour 
contrasts with that of FtsH which is essential for aerobic 
growth of E. coli [24~27]. The closely-related Rcalp is ob- 
viously unable to replace Afg3p function since: (i) comple- 
mentation of the strain DAY6 by the RCA1 gene does not 
restore wild-type growth (unpublished result); (ii) mitochond- 
rially-encoded proteins remain stable in the protease mutant 
PMY2 despite the presence of Rcalp (Fig. 1 ; panels B and E 
t = 0 vs. t = 30). This supports non-overlapping functions for 
Afg3p and Rcalp. 
For Ymelp, it was suggested that it could, through a cha- 
perone-like activity, control an assembly- or degradation-com- 
petent state of Cox2 [I1], thus preventing accumulation of 
unassembled subunits likely to interfere with complex assem- 
bly. If Afg3p fulfils a similar function, then the absence of 
chaperone activity in the disruption mutant would account for 
a weak respiratory function, since the generation time of 
DAY6 is strongly increased on a lactate-containing medium 
(Table 1). This interpretation is also supported by the finding 
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of strongly reduced bcl complex and cytochrome c oxidase 
activities in an AFG3-null mutant [9]. 
Recent genetic analysis has been shown that the degrada- 
tion of unassembled Cox2 requires three different proteins, 
only one of which (Osdlp/Ymelp) has so far been character- 
ized [11]. These proteins may form a complex which is re- 
quired for the assembly/degradation of Cox2. A similar situa- 
tion may hold for the remaining mitochondrial translation 
products, with an Afg3p-containing complex mediating as- 
sembly of newly synthesized mitochondrial translation pro- 
ducts into the various enzymes of the inner membrane. Inside 
this complex, the chaperone and protease activities of Afg3p 
may control the precise subunit stoichiometry of these en- 
zymes by regulating access to the assembling complex and/ 
or by contributing to the proteolytic degradation of mito- 
chondrially-coded subunits. Of great interest now is the ques- 
tion of how these different activities are balanced. 
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